Kisspeptin
Kisspeptin is the master upstream regulator of the reproductive axis — the peptide that tells the hypothalamus to release GnRH. Encoded by the KISS1 gene, kisspeptin binds KISS1R (GPR54) on hypothalamic GnRH neurons, triggering GnRH pulsatile release which then drives LH and FSH secretion. The discovery of kisspeptin's role (2003) was a paradigm shift in reproductive neuroendocrinology: loss-of-function KISS1R mutations cause hypogonadotropic hypogonadism, while gain-of-function causes precocious puberty. In clinical trials, kisspeptin-54 (the full-length active form) potently stimulates LH release in healthy men — a single 1 nmol/kg IV injection produces an 8-fold LH surge (Dhillo et al., 2005). Now being developed for IVF (oocyte maturation trigger with lower OHSS risk than HCG), functional hypothalamic amenorrhea, and as a diagnostic tool for HPG axis assessment. In the peptide/TRT space, kisspeptin represents the most upstream point of intervention possible — stimulating the entire cascade (GnRH → LH/FSH → testosterone/spermatogenesis) from the top. Research-phase for TRT adjunct use; the short half-life and need for frequent dosing are current limitations.
Current literature links
Evidence
No score yet
Safety
Unknown safety profile
Clinical Status
Phase II (fertility, IVF)
Last Sync
Not synced yet
Last Reviewed
Not reviewed yet
Dosing
Set height & weight in Settings to see your dose.
Pharmacology
Evidence Score
Plain-English Snapshot
Kisspeptin is currently categorized as a peptide compound.
Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.
Safety scoring is incomplete. Start conservatively and monitor carefully.
Core mechanism
KISS1R (GPR54) agonist on hypothalamic GnRH neurons; triggers GnRH pulsatile release → LH/FSH secretion. The most upstream activator of the reproductive axis.
Practical Context
Strongest current signals
No indexed study summaries yet.